Legal Opinion
Thant v. Rain Oncology Inc.
District Court, N.D. California
Decided February 24, 2025No. 5:23-cv-03518Unknown
1Opinion
1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 SAN JOSE DIVISION 7 8 MYO THANT, et al., Case No. 5:23-cv-03518-EJD 9 Plaintiffs, ORDER GRANTING IN PART AND DENYING IN PART MOTION TO 10 v. DISMISS 11 RAIN ONCOLOGY INC., et al., Re: ECF No. 53 Defendants. 12 13 When biopharmaceutical company Rain Oncology, Inc. announced negative clinical trial 14 results for its lead drug candidate, milademetan, its stock price sank. In response, investors sued 15 Rain and several of its officers and directors, alleging violations of federal securities law. Rain 16 and its fellow…
2Cases cited34 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Karim Khoja v. Orexigen Therapeutics, Inc.Court of Appeals for the Ninth Circuit · 2018
- In Re Gilead Sciences Securities LitigationCourt of Appeals for the Ninth Circuit · 2008
- Herman & MacLean v. HuddlestonSupreme Court of the United States · 1983
29 more not listed; retrieve them via the Exa API.